Outcomes of Laparoscopic Total Gastrectomy Combined With Spleen-Preserving Hilar Lymphadenectomy for Locally Advanced Proximal Gastric Cancer
暂无分享,去创建一个
J. Ji | Zekuan Xu | Guoxin Li | Chang-ming Huang | C. Zheng | Ping Li | Yong Li | Jian-kun Hu | Ziyu Li | Yihong Sun | P. Yu | Gang Zhao | X. Su | Wenbin Zhang | J. You | Lisheng Cai | Su Yan | J. Wan | Fangqin Xue | Yanchang Xu | Zuguang Wu | Dongbo Xu | Junpeng Lin | L. Fan | Jian-Xian Lin | Chang-ming Huang
[1] D. Park,et al. Long-Term Outcomes of Laparoscopic Distal Gastrectomy for Locally Advanced Gastric Cancer: The KLASS-02-RCT Randomized Clinical Trial. , 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2018 (5th edition) , 2020, Gastric Cancer.
[3] J. Ji,et al. Safety and feasibility of laparoscopic spleen-preserving No. 10 lymph node dissection for locally advanced upper third gastric cancer: a prospective, multicenter clinical trial , 2019, Surgical Endoscopy.
[4] D. Park,et al. Short-term Outcomes of a Multicenter Randomized Controlled Trial Comparing Laparoscopic Distal Gastrectomy With D2 Lymphadenectomy to Open Distal Gastrectomy for Locally Advanced Gastric Cancer (KLASS-02-RCT). , 2019, Annals of surgery.
[5] J. Ji,et al. Effect of Laparoscopic vs Open Distal Gastrectomy on 3-Year Disease-Free Survival in Patients With Locally Advanced Gastric Cancer: The CLASS-01 Randomized Clinical Trial. , 2019, JAMA.
[6] A. Jemal,et al. Cancer statistics, 2019 , 2019, CA: a cancer journal for clinicians.
[7] H. Xi,et al. Randomized controlled trial comparing short‐term outcomes of laparoscopic and open spleen‐preserving splenic hilar lymphadenectomy for advanced proximal gastric cancer: An interim report , 2018, Journal of surgical oncology.
[8] D. Graham,et al. Changing Trends in Stomach Cancer Throughout the World , 2017, Current Gastroenterology Reports.
[9] T. Yoshikawa,et al. Randomized Controlled Trial to Evaluate Splenectomy in Total Gastrectomy for Proximal Gastric Carcinoma , 2017, Annals of surgery.
[10] Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2014 (ver. 4) , 2016, Gastric Cancer.
[11] Zongguang Zhou,et al. Changes of Esophagogastric Junctional Adenocarcinoma and Gastroesophageal Reflux Disease Among Surgical Patients During 1988–2012 , 2015, Annals of surgery.
[12] D. Shin,et al. Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial. , 2014, The Lancet. Oncology.
[13] Y. Bang,et al. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial , 2012, The Lancet.
[14] D. Ichikawa,et al. Survival benefits from splenic hilar lymph node dissection by splenectomy in gastric cancer patients: relative comparison of the benefits in subgroups of patients , 2011, Gastric Cancer.
[15] S. Ohno,et al. Frequency of lymph node metastasis to the splenic hilus and effect of splenectomy in proximal gastric cancer. , 2009, Anticancer research.
[16] K. Yamashita,et al. Laparoscopy-assisted pancreas- and spleen-preserving total gastrectomy for gastric cancer as compared with open total gastrectomy , 2009, Surgical Endoscopy.
[17] M. Choi,et al. Clinical Significance of Splenic Hilar Lymph Node Metastasis in Proximal Gastric Cancer , 2009, Annals of Surgical Oncology.
[18] S. Choi,et al. Laparoscopic spleen-preserving splenic hilar lymph node dissection during total gastrectomy for gastric cancer. , 2008, Journal of the American College of Surgeons.
[19] H. Chung,et al. Randomized clinical trial of splenectomy versus splenic preservation in patients with proximal gastric cancer , 2006, The British journal of surgery.
[20] M. Ikeguchi,et al. Lymph Node Metastasis at the Splenic Hilum in Proximal Gastric Cancer , 2004, The American surgeon.
[21] A. Csendes,et al. A prospective randomized study comparing D2 total gastrectomy versus D2 total gastrectomy plus splenectomy in 187 patients with gastric carcinoma. , 2002, Surgery.
[22] M. Sasako,et al. New method to evaluate the therapeutic value of lymph node dissection for gastric cancer , 1995, The British journal of surgery.
[23] D. Park,et al. Long-term outcome of endoscopic submucosal dissection is comparable to that of surgery for early gastric cancer: a propensity-matched analysis , 2017, Gastric Cancer.
[24] Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3) , 2011, Gastric Cancer.